•
Sep 30, 2020

REGENXBIO Q3 2020 Earnings Report

Total Revenue
$98.9M
Previous year: $14.7M
+572.9%
EPS
$0.23
Previous year: -$0.94
-124.5%
Gross Profit
$81.5M
Previous year: $12.2M
+568.1%
Cash and Equivalents
$93.2M
Previous year: $79.6M
+17.1%
Free Cash Flow
-$42.5M
Previous year: -$31.8M
+33.6%
Total Assets
$541M
Previous year: $509M
+6.3%

REGENXBIO

REGENXBIO